Medicare Part D copays are set to rise on branded drugs

11/21/2011 | Sioux City Journal (Iowa)

Out-of-pocket costs that Medicare Part D enrollees will pay next year for brand-name drugs will rise by an average of 40% for preferred drugs and 30% for nonpreferred drugs, according to an Avalere Health study. Copays for nonpreferred generic drugs will drop by about 43% and will stay about the same for preferred generics, the study found.

View Full Article in:

Sioux City Journal (Iowa)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN